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We report nine travellers with confirmed chikungu-
nya virus infection, returning from tourist areas of 
Thailand to Sweden, Switzerland, the United Kingdom, 
Romania, Israel and France, diagnosed in January 
and February 2019. These sentinel tourists support 
the intensification of chikungunya virus circulation in 
Thailand and highlight the potential for importation to 
areas at risk of local transmission.
Since the start of 2019, the EuroTravNet/GeoSentinel 
and TropNet data collection networks for the surveil-
lance of travel-related morbidity have identified nine 
patients with chikungunya virus (CHIKV) infection 
imported from Thailand to Sweden, Switzerland, the 
United Kingdom (UK), Romania, Israel and France. 
In comparison, the last CHIKV infection reported to 
EuroTravNet/GeoSentinel in travellers from Thailand 
was a suspected case in Romania in January 2018. Only 
three other cases were reported to this network during 
the past 3 years from Thailand, and none in travellers 
returning to Europe. Here, we present the clinical and 
travel data of eight travellers notified to EuroTravNet/
GeoSentinel and one notified to TropNet with confirmed 
chikungunya disease imported from Thailand within 2 
months.
Characteristics of travellers returning from 
Thailand with chikungunya virus infection
The average length of stay of the nine travellers in 
Thailand was 22 days (range: 10–35 days) and the aver-
age delay between arrival in Thailand and onset of chi-
kungunya symptoms was 16 days (range: 5–22 days). 
Places visited by the travellers in the period before chi-
kungunya onset are shown in the Figure.
The patients’ median age was 37 years (range: 14–73 
years), and seven of the nine were female. Underlying 
conditions were reported in three patients (Table). 
Acute symptoms included fever and joints pains in all 
patients, seven had a rash, five reported headache, 
two had lymphadenitis, five developed oedema or joint 
swelling (acute thrombophlebitis was excluded in Case 
3). Case 8 experienced malaise, fever and loss of con-
sciousness and subsequent head trauma because of 
the fall. Three patients were hospitalised in Thailand 
(Cases 1, 3 and 8) and one after returning to their home 
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Figure 
Places of exposure visited by travellers before chikungunya virus infection, Thailand, January–February 2019 (n = 9)
THAILAND
Source: Map from Wikimedia Commons, the free media repository: https://commons.wikimedia.org/wiki/File:Thailand_Physiography.jpg
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country (Case 4); the remaining five were outpatients. 
All nine cases were confirmed after their return at the 
laboratory of the reporting site as detailed in the Table. 
Alternative diagnoses including arboviral infection 
with dengue and Zika viruses as well as malaria were 
ruled out at the time of chikungunya diagnosis using 
smear tests, dengue virus NS1-antigen, RT-PCR and/or 
serological tests depending on the delay since onset of 
symptoms and using tests referenced at the different 
diagnostic laboratories mentioned in the Table.
Eight of the nine CHIKV-infected travellers received 
non-steroidal anti-inflammatory drugs (NSAID) for per-
sistent arthralgia. Case 9 was treated with intravenous 
corticosteroids at the acute stage in Thailand. Only two 
travellers completely recovered within 3 weeks (Case 4 
and Case 8). In contrast, the woman in her 70s (Case 1) 
developed post-chikungunya chronic rheumatism (last-
ing more than 3 months). She is heavily impaired in her 
activities of daily life and has been referred to rheuma-
tology for evaluation.
Simultaneous case of dengue infection 
imported from Thailand 
A teenage sibling travelling with Case 4 developed fever 
4 days before leaving Thailand, followed by a petechial 
rash, mild arthralgia, nausea, vomiting and mild axil-
lary lymphadenitis. On the day after return to their 
country of residence, NS1 antigen was positive for den-
gue virus and RT-PCR for dengue-1 virus was positive 
in urine while RT-PCR and serology for CHIKV-infection 
were negative in serum [1]. Their parents travelling with 
them have remained asymptomatic.
Discussion
Beginning in October 2018, the Thai Ministry of Public 
Health reported a major increase in the number of chi-
kungunya cases in the country. In November alone, 
1,132 cases were reported, and by 10 December 2018, 
this had risen to 2,143 cases, compared with a total 
of 10 cases in 2017 [2]. From 1 January to 10 February 
2019, 1,652 patients from 17 provinces were reported; 
mostly affecting Phuket, Pattani, Songkhla, Narathiwat 
and Phang Nga provinces, with the highest morbidity 
rate in the southern region [3].
We suspect that all infections in our traveller case 
series were acquired in southern Thailand. For people 
who develop symptomatic chikungunya illness, the 
incubation period is typically 4–7 days (range: 1–12 
days) [4]. Bangkok was the point of entry (airport) with 
a short initial stop for Cases 3, 5, 6 and 8 who devel-
oped first symptoms, respectively, 18, 19, 20 and 11 
days after their arrival. Case 3 visited Chang Mai in the 
north of Thailand after the onset of chikungunya symp-
toms. Two patients developed chikungunya symptoms 
after spending at least 2 days in Phuket, two others in 
Koh Samui, and two others in Koh Lanta. One patient 
became symptomatic after returning to his country of 
residence.
These nine confirmed cases demonstrate that travel-
lers are currently at risk of CHIKV infection in many tour-
ist areas in southern Thailand. Only one of them had 
received pre-travel advice. Furthermore, in September 
2018, there was a report to EuroTravnet/GeoSentinel 
of a suspected chikungunya case in a traveller return-
ing from Malaysia to Spain, and chikungunya cases 
are currently reported from the Malaysian Ministry of 
Health [5], indicating an extension of this outbreak to 
neighbouring Asian countries. Given the global traffic 
to South East Asia, and Thailand in particular [6], there 
is a need to raise awareness to travellers and health-
care providers about the risk of arboviral diseases.
As confirmed by local sources [7], Case 4 and her sib-
ling attest that CHIKV and the endemic dengue virus 
are co-circulating in Thailand. The weekly number of 
dengue fever cases in Thailand seems similar to those 
recorded in 2018 at the same period with around 150 
cases per week in the South [8]. Furthermore, 15 den-
gue cases have been recorded in the GeoSentinel data-
base in travellers returned from Thailand since the 
start of 2019.
Prescription of NSAID for suspected arboviral disease 
imported from South East Asia should be contraindi-
cated when it is not possible to differentiate between 
dengue and chikungunya viruses, to avoid haemor-
rhagic complications. Besides, these are known to be 
more severe in patients with co-infections [9,10]. In 
addition, careful attention to adequate hydration is 
essential to minimise feelings of light-headedness and 
malaise [4].
A distinguishing characteristic of CHIKV infection, in 
contrast to dengue, are prolonged musculoskeletal dis-
orders [11]. In this case series, all adult women devel-
oped long-lasting joint pains; these symptoms were 
worst in the oldest case (Case 1) and in Case 9 who 
was treated early in her disease course with corticos-
teroids, which are not recommended because of the 
rebound effect after withdrawal [4]. The management 
of persistent pains relies mainly on a complete thera-
peutic dose of NSAID after the acute febrile stage, in 
combination with physical and rehabilitation medicine 
[4]. Populations at higher risk of complications, includ-
ing women older than 40 years, persons with underly-
ing rheumatic diseases and athletes, who are planning 
travel to Thailand and neighbouring countries, should 
be made aware of the risk of disabilities [11] and of the 
need for all-day preventive measures against vectors 
using physical (clothing, bed nets) and chemical (topi-
cal repellents with DEET and permethrin impregna-
tions) barriers [12].
The competent vector Aedes albopictus has become 
widely established in some parts of Europe and 
Israel since 1979. In 2006, CHIKV was first imported 
into Europe from outbreaks in the Indian Ocean [13]. 
Consequently, these locations are at risk of introduc-
tion and potential epidemics [14,15].
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Ae. albopictus can transmit CHIKV strains to a varying 
degree, depending on the viral genome and environ-
mental temperature [16]. There are three main geno-
types of CHIKV: Asian, West African and East/Central/
South African (ECSA). The Asian CHIKV, which is more 
easily transmitted by Ae. aegypti, caused the first 
documented outbreak in Thailand in 1958 [17] and has 
regularly circulated in South East Asia in recent years. 
However, it was an ECSA-mutated virus, well adapted 
to Ae. albopictus, that emerged on islands in the Indian 
Ocean in 2005, spread to Asia and was subsequently 
responsible for the re-emergence of chikungunya in 
Thailand in 2008 [18]. Autochthonous transmission 
events, following ECSA-CHIKV introductions through 
viraemic travellers, have occurred in Italy in 2007 and 
2017 [19] and in France in 2010, 2014 and 2017 [20]. 
Therefore, determining the CHIKV strain currently cir-
culating in Thailand is of importance to assess the risk 
of local transmission in Europe, especially before the 
period of seasonal activity of the vector Ae. albopictus.
Conclusion
These nine cases, occurring over a period of 2 months, 
indicate a rise in the number of travel-associated CHIKV 
infections in southern Thailand with a risk of importa-
tion to Europe. At the same time, they illustrate the 
long-term burden of chikungunya infection. Awareness 
among clinicians, information and appropriate man-
agement of travellers returning from Thailand and 
neighbouring countries, as well as early detection of 
imported cases and immediate mosquito control strat-
egies, are vital for preventing CHIKV dissemination and 
related morbidity.
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